Roblyer and BU BOTLab Highlighted in Boston Globe and ACS Podcast

The Boston Globe has released an article featuring a wearable breast cancer probe, the work of BME Associate Professor Darren Roblyer and the BU BOTLab (Biomedical Optical Technologies lab). The small, painless, wearable probe for breast cancer offers a new way to assess treatment response in real time to see if a patient is responding to pre-surgical chemotherapy, providing a pathway to personalize the treatment plan for each patient. Dr. Roblyer is a two-time American Cancer Society grantee, and the article is published to highlight Breast Cancer Awareness Month:

https://sponsored.bostonglobe.com/bg-brandlab/the-future-of-breast-cancer-treatment/  

 In addition, the American Cancer Society TheoryLab has just released a podcast of an interview with Prof. Roblyer, including how the technology can help identify who is or is not responding to chemotherapy in the first week of therapy.

itunes: 

https://podcasts.apple.com/us/podcast/monitoring-breast-tumors-with-a-small-wearable-probe/id1454395139?i=1000452439735

 spotify:

https://open.spotify.com/episode/2oh8pBt89Oaq4Q9CLBpOTz

 soundcloud: 

https://soundcloud.com/user-378624011/monitoring-breast-tumors-with-a-painless-wearable-probe